1 week Ago By Defense World Staff
PureTech Health plc (LON:PRTC – Get Free Report)’s share price traded up 12.2% during trading on Friday . The company traded as high as GBX 116 ($1.
52) and last traded at GBX 115.61 ($1.51).
3,062,196 shares were traded during mid-day trading, an increase of 184% from the average session volume of 1,076,575 shares. The stock had previously closed at GBX 103 ($1.35).
Analysts Set New Price TargetsSeparately, Jefferies Financial Group reissued a “buy” rating and set a GBX 455 ($5.96) target price on shares of PureTech Health in a research note on Monday, December 16th.Check Out Our Latest Analysis on PRTCPureTech Health Trading Up 14.
6 %The business has a fifty day moving average of GBX 135.24 and a 200-day moving average of GBX 148.08.
The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.
68. The company has a market capitalization of £354.45 million, a P/E ratio of -4.
84 and a beta of 1.02. PureTech Health Company Profile (Get Free Report)PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems.
The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.See AlsoFive stocks we like better than PureTech HealthInvesting in Commodities: What Are They? How to Invest in ThemRobinhood Strategies Could Be a Game-Changer for Young InvestorsHow to invest in marijuana stocks in 7 steps Are These 3 Retail Stocks Oversold or Really in Trouble?Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead.
